Enhanced Sensitivity to NVP-BEZ235 by Inhibition of p62/SQSTM1 in Human Bladder Cancer KoTCC-1 Cells Both In Vitro and In Vivo

Background/Aim: The prognosis of patients with invasive bladder cancer remains poor. The objective of this study was to evaluate the efficacy of NVP-BEZ235 (NVP), a dual PI3K/mTOR inhibitor, combined with the inactivation of p62/SQSTM1 (p62) in a human bladder cancer KoTCC-1 model. Materials and Met...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :In Vivo
Главные авторы: TAMURA, KEITA, WATANABE, KYOHEI, MATSUSHITA, YUTO, WATANABE, HIROMITSU, MOTOYAMA, DAISUKE, ITO, TOSHIKI, SUGIYAMA, TAKAYUKI, OTSUKA, ATSUSHI, MIYAKE, HIDEAKI
Формат: Artigo
Язык:Inglês
Опубликовано: International Institute of Anticancer Research 2020
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7279813/
https://ncbi.nlm.nih.gov/pubmed/32354885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11868
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы